A phase 1, open-label, drug-drug interaction study of rucaparib with rosuvastatin and oral contraceptives in patients with advanced solid tumors.

Autor: Liao M; Clinical Pharmacology, Clovis Oncology, Inc 5500 Flatrion Pkwy, Boulder, CO, 80301, USA., Jeziorski KG; Department of Gerontology, Public Health and Didactics, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland.; Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; BioVirtus Research Site Sp. Z.O.O., BioVirtus Medical Centre, Józefów, Poland., Tomaszewska-Kiecana M; BioVirtus Research Site Sp. Z.O.O., BioVirtus Medical Centre, Józefów, Poland., Láng I; Oncology Unit, Istenhegy Private Health Center, Budapest, Hungary., Jasiówka M; Gynecological Oncology Clinic, Centre of Oncology, Maria Skłodowska-Curie Memorial Institute, Krakow, Poland.; Pleiades Medical Centre, Krakow, Poland., Skarbová V; Department of Internal Medicine and Clinical Pharmacology, Summit Clinical Research, Bratislava, Slovakia., Centkowski P; Department of Oncology and Hematology, Provincial Specialist Hospital, Biala Podlaska, Poland., Ramlau R; Department of Oncology, Poznan University of Medical Sciences, Poznań, Poland., Górnaś M; Department of Chemotherapy, ATTIS Centre, Warsaw, Poland., Lee J; Regulatory Affairs, Clovis Oncology UK, Ltd., Cambridge, UK., Edwards S; Medical Affairs, Clovis Oncology UK, Ltd., Cambridge, UK., Habeck J; Biostatistics, Clovis Oncology, Inc., Boulder, CO, USA., Nash E; Clinical Operations, Clovis Oncology, Inc., Boulder, CO, USA., Grechko N; Clinical Science, Clovis Oncology UK, Ltd., Cambridge, UK., Xiao JJ; Clinical Pharmacology, Clovis Oncology, Inc 5500 Flatrion Pkwy, Boulder, CO, 80301, USA. jxiao@clovisoncology.com.

Publikováno v: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2021 Nov; Vol. 88 (5), pp. 887-897. Date of Electronic Publication: 2021 Aug 09.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

[Prognostic markers of advanced non-small cell lung carcinoma -  assessing the significance of oncomarkers using data-mining techiques RPA].

Autor: Cingelová S, Labudová V, Berkešová D, Dienerová M, Dammak A, Grmanová E, Nádaská O, Vasilenková I, Najšelová E, Skarbová V, Migašová M, Viktorínová Z, Jurga L

Publikováno v: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti [Klin Onkol] 2014; Vol. 27 (5), pp. 347-52.

Clinical Pharmacokinetics and Pharmacodynamics of Rucaparib.

Autor: Liao, Mingxiang, Beltman, Jeri, Giordano, Heidi, Harding, Thomas C., Maloney, Lara, Simmons, Andrew D., Xiao, Jim J.

Publikováno v: Clinical Pharmacokinetics; Nov2022, Vol. 61 Issue 11, p1477-1493, 17p